Company intelligence
Eurofins BioPharma Product Testing North America
Largest scope of global services, Sharpest focus on data integrity.
About Eurofins BioPharma Product Testing North America
Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies. Our comprehensive service offerings include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products. We offer a broad range of methodologies under GMP authorization, ISO 17025 accreditation and ISO 9000 certification and all analysis are performed according to Ph. Eur., BP, USP, and JP, as well as specific customer methods. With a global capacity of more than 2 million square feet, our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across more than 50 locations worldwide. Our local presence with 15 sites in North America, including CA, FL, IN, MI, MO, NC, NJ, PA and Toronto, Canada ensures personal service backed by a unique global breadth of harmonized capabilities that supports all functional areas of bio/pharmaceutical drug development. We give clients the flexibility to choose from three service models to meet specific project needs and we also provide secure 24-hour data access via our online data portal, LabAccess.com.
Verified activity
Signals from Eurofins BioPharma Product Testing North America
4 published signals
Presence & Recognition
Eurofins BioPharma Product Testing North America is hosting an online discussion on September 22 on the future of rapid mycoplasma testing.
Reported by Eurofins BioPharma Product Testing North America
Presence & Recognition
Eurofins BioPharma Product Testing North America announced Zeeshan Shaikh, MSc, attending the Neuropsychiatric Drug Summit in Boston, MA from September 15-17 to discuss analytical continuity across development.
Reported by Jessica Topolewski
Presence & Recognition
Eurofins BioPharma Product Testing North America announced that Zeeshan Shaikh, MSc, will be attending the Neuropsychiatric Drug Summit in Boston, MA from September 15-17 to discuss analytical continuity across development.
Reported by Arizza Chiara Ibanez
Presence & Recognition
Eurofins BioPharma Product Testing North America hosted Zeeshan Shaikh at the Neuropsychiatric Drug Summit to discuss analytical continuity across development for neuropsychiatric and psychedelic therapy programs.
Reported by Eurofins BioPharma Product Testing North America